at illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. these studies will help make the realization of personalized medicine possible. with such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. as a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. illumina’s innovative, array-based solutions for dna, rna, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Company profile
Ticker
ILMN
Exchange
Website
CEO
Francis deSouza
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Agilent • Waters • Bio-Rad Laboratories • Avantor • Mettler-Toledo International • Bruker • Revvity • Seer • Prenetics Global Limited • Cue Health ...
Former names
ILLUMINA INC
SEC CIK
Corporate docs
Subsidiaries
Advanced Liquid Logic Inc. • BlueBee Belgium BVBA • BlueBee Holding BV • Conexio Genomics Pty Ltd. • Emedgene Technologies Ltd • GRAIL, LLC • IDbyDNA Inc. • Illumina AB • Illumina Australia • Illumina Austria GmbH ...
IRS number
330804655
ILMN stock data
Latest filings (excl ownership)
8-K/A
Cost Associated with Exit or Disposal Activities
9 Nov 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2023
9 Nov 23
8-K/A
Departure of Directors or Certain Officers
8 Nov 23
8-K/A
Submission of Matters to a Vote of Security Holders
18 Oct 23
8-K
Departure of Directors or Certain Officers
8 Sep 23
8-K
Illumina’s Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer
5 Sep 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
Dr. Steven Barnard Appointed Chief Technology Officer
9 Aug 23
8-K
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2023
9 Aug 23
Transcripts
ILMN
Earnings call transcript
2023 Q3
9 Nov 23
ILMN
Earnings call transcript
2023 Q2
9 Aug 23
ILMN
Earnings call transcript
2023 Q1
25 Apr 23
ILMN
Earnings call transcript
2022 Q4
7 Feb 23
ILMN
Earnings call transcript
2022 Q3
4 Nov 22
ILMN
Earnings call transcript
2022 Q2
11 Aug 22
ILMN
Earnings call transcript
2022 Q1
6 May 22
ILMN
Earnings call transcript
2021 Q4
11 Feb 22
ILMN
Earnings call transcript
2021 Q3
5 Nov 21
ILMN
Earnings call transcript
2021 Q2
6 Aug 21
Latest ownership filings
Financial summary
| Quarter (USD) | Oct 23 | Jul 23 | Apr 23 | Jan 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Jan 23 | Jan 22 | Jan 21 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 927.00 mm | 927.00 mm | 927.00 mm | 927.00 mm | 927.00 mm | 927.00 mm |
| Cash burn (monthly) | 208.67 mm | 6.08 mm | 260.67 mm | 93.08 mm | (no burn) | (no burn) |
| Cash used (since last report) | 432.53 mm | 12.61 mm | 540.31 mm | 192.94 mm | n/a | n/a |
| Cash remaining | 494.47 mm | 914.39 mm | 386.69 mm | 734.06 mm | n/a | n/a |
| Runway (months of cash) | 2.4 | 150.3 | 1.5 | 7.9 | n/a | n/a |
Institutional ownership, Q3 2023
92.9% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 793 |
| Opened positions | 87 |
| Closed positions | 157 |
| Increased positions | 238 |
| Reduced positions | 341 |
| 13F shares | Current |
|---|---|
| Total value | 19.55 tn |
| Total shares | 147.54 mm |
| Total puts | 1.60 mm |
| Total calls | 1.56 mm |
| Total put/call ratio | 1.0 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 17.97 mm | $2.47 tn |
| BLK Blackrock | 13.33 mm | $1.83 tn |
| Baillie Gifford & Co | 10.47 mm | $1.44 tn |
| Edgewood Management | 6.58 mm | $902.79 bn |
| STT State Street | 6.52 mm | $894.70 bn |
| Polen Capital Management | 5.13 mm | $703.78 bn |
| Growth Fund Of America | 4.99 mm | $1.50 bn |
| Wellington Management | 4.97 mm | $681.61 bn |
| JHG Janus Henderson | 4.75 mm | $651.80 bn |
| Loomis Sayles & Co L P | 4.01 mm | $552.31 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Nov 23 | Hoyt Aimee L | Common Stock | Sell | Dispose S | No | No | 112.84 | 315 | 35.54 k | 8,314 |
| 5 Nov 23 | Steven Barnard | Common Stock | Payment of exercise | Dispose F | No | No | 112.84 | 553 | 62.40 k | 21,657 |
| 5 Nov 23 | Charles Dadswell | Common Stock | Payment of exercise | Dispose F | Yes | No | 112.84 | 1,523 | 171.86 k | 15,483 |
| 5 Nov 23 | Scott D Ericksen | Common Stock | Payment of exercise | Dispose F | No | No | 112.84 | 306 | 34.53 k | 7,733 |
| 5 Nov 23 | Joydeep Goswami | Common Stock | Payment of exercise | Dispose F | No | No | 112.84 | 1,887 | 212.93 k | 18,777 |
News
Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations
24 Nov 23
Half Of S&P 500 Stocks Still Below 200-Day Average, Ignoring Covid-Like Rally: 10 Bargain Plays For Latecomer Bulls
21 Nov 23
Piper Sandler Maintains Overweight on Illumina, Lowers Price Target to $190
13 Nov 23
Tech Stocks Soar, Microsoft Reaches Record High As AI Rally Resumes: What's Driving Markets Friday?
10 Nov 23
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
10 Nov 23
Press releases
ILLUMINA SHAREHOLDER ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options
2 Dec 23
ROSEN, A LEADING LAW FIRM, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – ILMN
1 Dec 23
DEADLINE ALERT for FMC, ILMN, PAYC, JRVR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
1 Dec 23
HAGENS BERMAN Alerts Illumina (ILMN) Investors to Filing of Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm's Attorneys
1 Dec 23
DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
1 Dec 23